- Home
- ARTW vs FBRX Comparison
ARTW vs FBRX Comparison
Compare ARTW & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTW
- FBRX
- Stock Information
- Founded
- ARTW 1956
- FBRX N/A
- Country
- ARTW United States
- FBRX United States
- Employees
- ARTW N/A
- FBRX N/A
- Industry
- ARTW Industrial Machinery/Components
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- ARTW Industrials
- FBRX Health Care
- Exchange
- ARTW Nasdaq
- FBRX Nasdaq
- Market Cap
- ARTW 8.7M
- FBRX 8.3M
- IPO Year
- ARTW N/A
- FBRX N/A
- Fundamental
- Price
- ARTW $1.70
- FBRX $5.95
- Analyst Decision
- ARTW
- FBRX Strong Buy
- Analyst Count
- ARTW 0
- FBRX 3
- Target Price
- ARTW N/A
- FBRX $77.58
- AVG Volume (30 Days)
- ARTW 16.6K
- FBRX 13.6K
- Earning Date
- ARTW 10-04-2024
- FBRX 11-14-2024
- Dividend Yield
- ARTW N/A
- FBRX N/A
- EPS Growth
- ARTW N/A
- FBRX N/A
- EPS
- ARTW N/A
- FBRX N/A
- Revenue
- ARTW $25,181,639.00
- FBRX N/A
- Revenue This Year
- ARTW N/A
- FBRX N/A
- Revenue Next Year
- ARTW N/A
- FBRX N/A
- P/E Ratio
- ARTW N/A
- FBRX N/A
- Revenue Growth
- ARTW N/A
- FBRX N/A
- 52 Week Low
- ARTW $1.33
- FBRX $4.11
- 52 Week High
- ARTW $2.37
- FBRX $21.25
- Technical
- Relative Strength Index (RSI)
- ARTW 54.73
- FBRX 65.56
- Support Level
- ARTW $1.58
- FBRX $4.44
- Resistance Level
- ARTW $1.74
- FBRX $5.90
- Average True Range (ATR)
- ARTW 0.06
- FBRX 0.37
- MACD
- ARTW 0.01
- FBRX 0.21
- Stochastic Oscillator
- ARTW 81.82
- FBRX 100.00
About ARTW Art's-Way Manufacturing Co. Inc.
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world-wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).